<p>(A, B) Co-immunoprecipitation assay in N2aC24 cells with SAF61 anti-PrP Ab (A) or rabbit polyclonal anti-sortilin Abs (B). Arrows and arrowheads indicate a non-specific signal of the degraded fragment of protein G or the light chain of antibodies used in co-immunoprecipitation. Percentages indicate the proportion of the sample loaded. (C) GST-pulldown assay using GST-tagged VPS10P domain of sortilin and His-tagged full-length recombinant PrP or His-tagged recombinant PrP lacking residues 23–88. Percentages indicate the proportion of the sample loaded. (D) Co-immunoprecipitation assay in mouse brain homogenate with SAF61 anti-PrP Ab. Percentages indicate the proportion of the sample loaded. Arrowheads indicate a non-specific signal of the...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...
<div><p>Molecules that inhibit the formation of an abnormal isoform of prion protein (PrP<sup>Sc</su...
<p><b>A</b>. Schematic representation of the cell/brain-PMCA propagation study. Brain-derived PrP<su...
<p><b>(A)</b> Brain homogenate from wild-type (C57BL/6J) and <i>Prnp</i><sup><i>o/o</i></sup> mice w...
<p>(A) Western blotting of various tissues from C57BL/6 WT and <i>Prnp</i><sup><i>0/0</i></sup> mice...
<p><b>A</b>. PrP<sup>Sc</sup> immunostaining (brown+arrow) using Saf84 anti-PrP antibody in the late...
<p>(<b>A</b>) Colocalization of sortilin and APP. Mouse cortical neuron (upper) and brain cortex (lo...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
<p>(A) Comparison of the PrP<sup>C</sup> levels in cell lines and brain homogenate. Western blotting...
<p><b>A-C</b>) High magnification immunofluorescence images of double-labeled (NG2-PrP<sup>c</sup>) ...
<p>(A): Caco-2/TC7 cells were transfected by PrP<sup>c</sup>-siRNA 3 days after seeding and the expr...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
International audiencePrion diseases are transmissible neurodegenerative disorders affecting humans ...
Prion diseases are a group of fatal neurodegenerative disorders caused by prions, which consist main...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...
<div><p>Molecules that inhibit the formation of an abnormal isoform of prion protein (PrP<sup>Sc</su...
<p><b>A</b>. Schematic representation of the cell/brain-PMCA propagation study. Brain-derived PrP<su...
<p><b>(A)</b> Brain homogenate from wild-type (C57BL/6J) and <i>Prnp</i><sup><i>o/o</i></sup> mice w...
<p>(A) Western blotting of various tissues from C57BL/6 WT and <i>Prnp</i><sup><i>0/0</i></sup> mice...
<p><b>A</b>. PrP<sup>Sc</sup> immunostaining (brown+arrow) using Saf84 anti-PrP antibody in the late...
<p>(<b>A</b>) Colocalization of sortilin and APP. Mouse cortical neuron (upper) and brain cortex (lo...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
<p>(A) Comparison of the PrP<sup>C</sup> levels in cell lines and brain homogenate. Western blotting...
<p><b>A-C</b>) High magnification immunofluorescence images of double-labeled (NG2-PrP<sup>c</sup>) ...
<p>(A): Caco-2/TC7 cells were transfected by PrP<sup>c</sup>-siRNA 3 days after seeding and the expr...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
International audiencePrion diseases are transmissible neurodegenerative disorders affecting humans ...
Prion diseases are a group of fatal neurodegenerative disorders caused by prions, which consist main...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...
<div><p>Molecules that inhibit the formation of an abnormal isoform of prion protein (PrP<sup>Sc</su...